Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells - PubMed (original) (raw)
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
Manuelle Viguier et al. J Immunol. 2004.
Abstract
Dominant tolerance is mediated by regulatory T cells (T(reg)) that control harmful autoimmune T cells in the periphery. In this study, we investigate the implication of T(reg) in modulating infiltrating T lymphocytes in human metastatic melanoma. We found that CD4(+)CD25(high) T cells are overrepresented in metastatic lymph nodes (LNs) with a 2-fold increased frequency compared with both tumor-free LNs and autologous PBMCs. These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire. They inhibit in vitro the proliferation and cytokine production of infiltrating CD4(+)CD25(-) and CD8(+) T cells (IL-2, IFN-gamma) through a cell-contact-dependent mechanism, thus behaving as T(reg). In some cases, the presence of T(reg) type 1/Th3-like lymphocytes could also be demonstrated. Thus, T(reg) are a major component of the immunosuppressive microenvironment of metastatic melanoma LNs. This could explain the poor clinical response of cancer patients under immunotherapeutic protocols, and provides a new basis for future immunotherapeutic strategies counteracting in vivo T(reg) to reinforce local antitumor immune responses.
Similar articles
- Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B. Knol AC, et al. Exp Dermatol. 2008 May;17(5):436-45. doi: 10.1111/j.1600-0625.2007.00681.x. Epub 2008 Feb 27. Exp Dermatol. 2008. PMID: 18312383 - Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M, Pircher H, Di Nicola M, Mortarini R. Anichini A, et al. Cancer Res. 2010 Nov 1;70(21):8378-87. doi: 10.1158/0008-5472.CAN-10-2028. Epub 2010 Sep 21. Cancer Res. 2010. PMID: 20861189 - Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.
Baumgartner J, Wilson C, Palmer B, Richter D, Banerjee A, McCarter M. Baumgartner J, et al. J Surg Res. 2007 Jul;141(1):72-7. doi: 10.1016/j.jss.2007.03.053. J Surg Res. 2007. PMID: 17574040 Free PMC article. - Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
Poggi A, Zocchi MR. Poggi A, et al. Hum Immunol. 2008 Nov;69(11):755-9. doi: 10.1016/j.humimm.2008.08.278. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817823 Review. - Human CD4+CD25+ regulatory T cells.
Baecher-Allan C, Viglietta V, Hafler DA. Baecher-Allan C, et al. Semin Immunol. 2004 Apr;16(2):89-98. doi: 10.1016/j.smim.2003.12.005. Semin Immunol. 2004. PMID: 15036232 Review.
Cited by
- Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers.
He R, Lu J, Feng J, Lu Z, Shen K, Xu K, Luo H, Yang G, Chi H, Huang S. He R, et al. Front Immunol. 2024 Jul 4;15:1435187. doi: 10.3389/fimmu.2024.1435187. eCollection 2024. Front Immunol. 2024. PMID: 39026661 Free PMC article. Review. - Mechanisms of Altered Immune Response in Skin Melanoma.
Fruntealată RF, Marius M, Boboc IKS, Mitran SI, Ciurea ME, Stoica GA. Fruntealată RF, et al. Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30. Curr Health Sci J. 2023. PMID: 38314217 Free PMC article. Review. - Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Kostecki KL, Iida M, Crossman BE, Salgia R, Harari PM, Bruce JY, Wheeler DL. Kostecki KL, et al. Cancers (Basel). 2024 Jan 11;16(2):312. doi: 10.3390/cancers16020312. Cancers (Basel). 2024. PMID: 38254801 Free PMC article. Review. - Alleviating hypoxia to improve cancer immunotherapy.
Fan P, Zhang N, Candi E, Agostini M, Piacentini M; TOR Centre; Shi Y, Huang Y, Melino G. Fan P, et al. Oncogene. 2023 Dec;42(49):3591-3604. doi: 10.1038/s41388-023-02869-2. Epub 2023 Oct 26. Oncogene. 2023. PMID: 37884747 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials